Meta Biomed Co. Ltd (059210) - Total Liabilities

Latest as of September 2025: ₩58.87 Billion KRW ≈ $39.90 Million USD

Based on the latest financial reports, Meta Biomed Co. Ltd (059210) has total liabilities worth ₩58.87 Billion KRW (≈ $39.90 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Meta Biomed Co. Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Meta Biomed Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 059210 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Meta Biomed Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Meta Biomed Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
IB Acquisition Corp. Common Stock NASDAQ:IBAC	USA	$1.16 Million
Emc Gold Corporation AU:EM3	Australia	AU$2.68 Million
Global Mofy Metaverse Limited Ordinary Shares NASDAQ:GMM	USA	$16.07 Million
AFC Gamma Inc NASDAQ:AFCG	USA	$100.03 Million
Microcosm Technology Co Ltd TWO:3354	Taiwan	NT$133.39 Million
Kredyt Inkaso SA WAR:KRI	Poland	zł564.43 Million
Evertex Fabrinology Ltd TW:1470	Taiwan	NT$196.08 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Meta Biomed Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Meta Biomed Co. Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Meta Biomed Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Meta Biomed Co. Ltd (2011–2024)

The table below shows the annual total liabilities of Meta Biomed Co. Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩83.96 Billion ≈ $56.90 Million	+46.11%
2023-12-31	₩57.46 Billion ≈ $38.94 Million	-4.99%
2022-12-31	₩60.48 Billion ≈ $40.99 Million	+34.99%
2021-12-31	₩44.80 Billion ≈ $30.36 Million	-25.17%
2020-12-31	₩59.88 Billion ≈ $40.58 Million	+19.70%
2019-12-31	₩50.02 Billion ≈ $33.90 Million	+4.82%
2018-12-31	₩47.72 Billion ≈ $32.34 Million	-35.21%
2017-12-31	₩73.65 Billion ≈ $49.91 Million	+7.54%
2016-12-31	₩68.49 Billion ≈ $46.41 Million	+8.86%
2015-12-31	₩62.91 Billion ≈ $42.64 Million	-11.21%
2014-12-31	₩70.85 Billion ≈ $48.02 Million	-1.93%
2013-12-31	₩72.25 Billion ≈ $48.96 Million	+15.52%
2012-12-31	₩62.54 Billion ≈ $42.39 Million	+321.41%
2011-12-31	₩14.84 Billion ≈ $10.06 Million	--

About Meta Biomed Co. Ltd

KQ:059210 Korea Healthcare Equipment & Supplies

Market Cap

$61.85 Million

₩91.27 Billion KRW

Market Cap Rank

#21123 Global

#1199 in Korea

Share Price

₩3885.00

Change (1 day)

+1.83%

52-Week Range

₩3385.00 - ₩6520.00

All Time High

₩6954.44